DEVELOPMENT OF T CELL-BASED IMMUNOTHERAPIES TO TARGET DORMANT DISSEMINATED BREAST CANCER CELLS

被引：0
|
作者：
Goddard, Erica [1 ]
Srivastava, Shivani [1 ]
Riddell, Stanley [1 ]
Ghajar, Cyrus [1 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2020年 / 8卷
关键词：
RECURRENCE;
D O I：
10.1136/jitc-2020-SITC2020.0113
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
113
引用
收藏
页码：A70 / A70
页数：1
相关论文
共 50 条
  • [41] NK Cell-based Immunotherapies: Awakening the Innate Anti-cancer Response
    Souza-Fonseca-Guimaraes, Fernando
    DISCOVERY MEDICINE, 2016, 21 (115) : 197 - 203
  • [42] Targeting CD276 for T cell-based immunotherapy of breast cancer
    Hagelstein, Ilona
    Wessling, Laura
    Rochwarger, Alexander
    Zekri, Latifa
    Klimovich, Boris
    Tegeler, Christian M.
    Jung, Gundram
    Schuerch, Christian M.
    Salih, Helmut R.
    Lutz, Martina S.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [43] Tumour-associated macrophages as a potential target to improve natural killer cell-based immunotherapies
    Kitamura, Takanori
    ESSAYS IN BIOCHEMISTRY, 2023, 67 (06) : 1003 - 1014
  • [44] Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
    Hegde, Upendra P.
    Mukherji, Bijay
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1113 - 1121
  • [45] Monitoring circulating γδ T cells in cancer patients to optimize γδ T cell-based immunotherapy
    Oberg, Hans-Heinrich
    Kellner, Christian
    Peipp, Matthias
    Sebens, Susanne
    Adam-Klages, Sabine
    Gramatzki, Martin
    Kabelitz, Dieter
    Wesch, Daniela
    FRONTIERS IN IMMUNOLOGY, 2014, 5
  • [46] Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
    Upendra P. Hegde
    Bijay Mukherji
    Cancer Immunology, Immunotherapy, 2017, 66 : 1113 - 1121
  • [47] The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies
    Bald, Tobias
    Krummel, Matthew F.
    Smyth, Mark J.
    Barry, Kevin C.
    NATURE IMMUNOLOGY, 2020, 21 (08) : 835 - 847
  • [48] Characterization of human prostate and breast cancer cell lines for experimental T cell-based immunotherapy
    Carlsson, Bjorn
    Forsberg, Ole
    Bengtsson, Mats
    Totterman, Thomas H.
    Essand, Magnus
    PROSTATE, 2007, 67 (04): : 389 - 395
  • [49] Developing the Quantitative Cell-Based Bioassays for the Discovery and Development of T Cell-Based Therapies
    Machleidt, Kara
    Grailer, Jamison
    Gilden, Julia
    Slater, Michael
    Stecha, Pete
    Hartnett, Jim
    Lazar, Dan
    Fan, Frank
    Cong, Mei
    Cheng, Zhijie Jey
    MOLECULAR THERAPY, 2021, 29 (04) : 332 - 332
  • [50] In Vivo Murine-Matured Human CD3+ Cells as a Preclinical Model for T Cell-Based Immunotherapies
    Haworth, Kevin G.
    Ironside, Christina
    Norgaard, Zachary K.
    Obenza, Willimark M.
    Adair, Jennifer E.
    Kiem, Hans-Peter
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2017, 6 : 17 - 30
12345